Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1001918

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether officials in his Department have had discussions with the Scottish Government on the (a) Patient and Clinician Engagement system, (b) its effect on approval rates for new rare disease medicines in Scotland and (c) potential lessons from that system for NHS England.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	188233
answer	answer is ministerial correction date of answer 14/11/2018 answer text <p>Officials have had no such discussions. Health is a devolved matter and the availability of medicines for the treatment of rare diseases in Scotland is an issue for the Scottish Government.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/11/2018 11:21:33 answering member 4067 label Biography information for Steve Brine
tabling member	4637 label Biography information for James Frith

1001919

registered interest
date	05/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to paragraph 4.12 the UK Rare Diseases Strategy, what assessment his Department has made of whether the National Institute for Health and Care Excellence’s Single Technology Appraisal Programme meets the ambition of suitability for assessing rare disease treatments.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	188234
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>Where a company is willing to set a fair price for a drug, the National Institute for Health and Care Excellence (NICE) technology appraisal process has been proven to be suitable for the assessment of drugs for rare diseases. NICE has been able to recommend a number of drugs for patients with rare diseases through its technology appraisal programme; recent examples include dinutuximab beta for neuroblastoma and daratumumab for relapsed and refractory multiple myeloma.</p><p> </p><p>With the aim of improving the lives of all those affected by a rare disease, the United Kingdom Government published the UK Strategy for Rare Diseases in 2013, a high-level framework containing 51 commitments which sets out a seven-year strategic vision (2013-2020). The Government is committed to implementing the Strategy’s commitments and has, in January 2018, published Implementation Plans setting out its actions for England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/11/2018 17:23:30 answering member 4067 label Biography information for Steve Brine
tabling member	4637 label Biography information for James Frith

999587

registered interest
date	01/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of NHS England’s outturn expenditure against its £25 million budget for discretionary investment in specialised services in (a) 2016-17 and (b) 2017-18.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	187127
answer	answer is ministerial correction date of answer 09/11/2018 answer text <p>NHS England’s outturn expenditure against its £25 million budget for discretionary investment in specialised services is not separately identified within the overall specialised commissioning spend. Therefore, no estimate can be made on actual spend on the discretionary investments approved for specialised services for 2016-17 and 2017-18.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/11/2018 10:02:44 answering member 4067 label Biography information for Steve Brine
tabling member	4637 label Biography information for James Frith

989466

registered interest
date	17/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Audiology: Paediatrics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of audiologists specialising in paediatrics that will be needed up to 2020.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	180851
answer	answer is ministerial correction date of answer 22/10/2018 answer text <p>Data on local National Health Service plans covering the number of audiologists specialising in paediatrics that will be needed up to 2020 is not collected centrally. Responsibility for assessing and managing staffing levels, including specialty staff, rests with individual NHS trusts and their boards who are best placed to decide how many staff they need to provide a given service.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/10/2018 16:15:40 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4637 label Biography information for James Frith

987926

registered interest
date	15/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Audiology: Paediatrics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many training places were available for audiologists specialising in paediatrics; how many of those places were filled; and how many such students graduated in each of the last five years.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	179299
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>The Department does not hold data related to the training of audiologists that specialise in paediatrics.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 23/10/2018 11:26:38 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4637 label Biography information for James Frith

987928

registered interest
date	15/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Illness
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people with mental health problems who (a) live in social rented property and (b) are homeowners; and what recent discussions he has had with the Secretary of State for Housing, Communities and Local Government on the issues raised by those people and the medical staff who treat them.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	179300
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>The Department has made no such assessment. Ministers meet regularly to discuss a range of issues.</p> answering member constituency West Suffolk answering member printed Matt Hancock question first answered 23/10/2018 11:29:19 answering member 4070 label Biography information for Matt Hancock
tabling member	4637 label Biography information for James Frith

967794

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	IVF
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much money from the public purse has been spent commissioning IVF services in England in each of the last five years.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	170429
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>This information is not collected centrally.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 12/09/2018 11:46:32 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4637 label Biography information for James Frith

934134

registered interest
date	03/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Examiners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Secretary of State for Health and Social Care of 16 June 2018, Official Report, column 178, what progress his Department has made on appointing independent medical examiners.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	160347
answer	answer is ministerial correction date of answer 06/07/2018 answer text <p>On 11 June, the Government published its response to consultation on the introduction of medical examiners and reforms to death certification in England and Wales. This set out plans to introduce a system of medical examiners from April 2019.</p><p> </p><p>Medical examiners will scrutinise all non-coronial deaths, improve the quality and accuracy of the Medical Certificate of Cause of Death, improve national data on avoidable mortality and contribute to improved patient safety.</p><p> </p><p>Medical examiners will provide a service to the bereaved, increasing transparency and offering them the opportunity to raise concerns. They will provide a new level of scrutiny to help deter criminal activity and poor practice. On 18 June, the Government commenced section 21 of the Coroners and Justice Act 2009, to allow for the appointment of a National Medical Examiner to prepare guidance that will support the introduction of medical examiners. The Government is working with a range of stakeholders, including in the National Health Service, to establish delivery arrangements.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 06/07/2018 08:54:56 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4637 label Biography information for James Frith

904712

registered interest
date	15/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Abortion: Misoprostol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to review the value and safety of the regulations under the 1967 Abortion Act relating to the home use of misoprostol for women who are having an early medical abortion.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	144401
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>The Government’s priority is to ensure that women who require abortion services have access to safe, high-quality care. Abortions in England must be performed under the legal framework set by the Abortion Act 1967. We are not currently in a position to recommend that the home be approved as a class of place under Section 1(3)(a) of the Abortion Act in England. However, we are keeping the position under review, including reviewing the available evidence, and having regard to the ongoing legal proceedings concerning home use in Scotland.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/05/2018 15:31:23 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4637 label Biography information for James Frith

887152

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of funding required to raise awareness of the potential health risks for women of child-bearing age of taking Sodium Valproate.
tabling member constituency	Bury North
tabling member printed	James Frith
uin	136717
answer	answer is ministerial correction date of answer 27/04/2018 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has been working in partnership with the Department, professional bodies and the healthcare system to bring together a package of measures to raise awareness of the significant risks associated with sodium valproate in pregnancy and to support healthcare professionals in changing prescribing behaviour and therefore reducing the harms from valproate in women of child-bearing age. All parties involved are fully committed to the implementation of the new regulatory position using the existing funds of each relevant organisation.</p><p> </p><p>The new measures include updated educational materials for healthcare professionals and patients and will be communicated through the MHRA bulletin and letters to healthcare professionals through the National Health Service Central Alerting System. The information cascade will be supported by messages from professional bodies, charities and patient groups to their constituents and reinforced through changes to clinical guidelines and improved alerts on General Practitioner prescribing systems.</p><p> </p><p>The effectiveness of the new measures in changing prescribing of valproate will be closely monitored. Relevant data will be published and there will be ongoing follow up to ensure that the harms to the child from valproate in pregnancy are minimised.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 27/04/2018 12:52:30 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4637 label Biography information for James Frith